Try our Advanced Search for more refined results
Intellectual Property
-
April 07, 2026
Squires Panel To Rehear Herd Management Patent Invalidation
U.S. Patent and Trademark Office Director John Squires has convened a rehearing panel to reconsider whether a Patent Trial and Review Board decision that invalidated an animal management patent had done so properly.
-
April 07, 2026
Cisco's Win After Sunk 10-Figure Judgment Eyed By Fed. Circ.
A Federal Circuit panel on Tuesday grappled with whether a Virginia federal judge got it right when she found that Cisco did not infringe three Centripetal Networks cybersecurity patents, after the appeals court discarded a multibillion-dollar judgment against Cisco due to another judge's stock conflict.
-
April 07, 2026
Pickleball Paddle Maker Calls Fault On Rivals' Imports At ITC
Pickleball paddles made by Adidas, Franklin and nine other rival companies infringe two patents held by a Maryland manufacturer, it told the U.S. International Trade Commission on Tuesday, asking the ITC to block imports of the paddles.
-
April 07, 2026
3rd Circ. Rules No Infringement In Posting Of Building Codes
In a precedential opinion Tuesday, the Third Circuit ruled that a company's posting of the American Society for Testing and Materials' copyrighted technical standards online was a fair use of the information that did not infringe ASTM's copyright.
-
April 07, 2026
Fed. Circ. Tosses PTAB Amendment Appeal Over Standing
The Federal Circuit won't reconsider the Patent Trial and Appeal Board's decision to amend a Digital Turbine Inc. mobile device installation patent, saying Tuesday that challenger ironSource Ltd. doesn't have standing to appeal.
-
April 07, 2026
Ga. Panel Vacates $662K Interest On $2M Arbitration Award
A Georgia Court of Appeals panel on Tuesday vacated about $662,000 in interest that was tacked onto an arbitration award in a trade secrets dispute between two medical device companies, ruling that while the assessment of interest was justified, a trial court had miscalculated the total.
-
April 07, 2026
Fed. Circ. Affirms Samsung PTAB Wins On Display Patents
The Federal Circuit on Tuesday affirmed a decision from the Patent Trial and Appeal Board that invalidated patents asserted against Samsung covering cooling systems for electronic displays.
-
April 07, 2026
Conn. Finance Firm, Ex-Adviser Settle Trade Secrets Claims
Connecticut financial firm Ridgeline Financial Partners LLC has settled a lawsuit accusing a former adviser of taking trade secrets and asking clients to join his own competing company, Crionna Wealth LLC.
-
April 07, 2026
Holland & Knight Hires Broadcasters Trade Group VP In DC
Holland & Knight LLP has hired the National Association of Broadcasters' vice president of public policy in Washington, D.C., as a partner with its public policy and regulation group, the firm said Tuesday.
-
April 07, 2026
Squires Rejects 2 PTAB Petitions, Grants 2 In Merits Orders
U.S. Patent and Trademark Office Director John Squires has shot down a pair of requests from automakers Kia and Toyota challenging vehicle technology patents, while granting a separate duo of challenges Amazon had asked for.
-
April 07, 2026
MLB Players, DraftKings Settle Suit Over Use Of Player Images
A Major League Baseball Players Association subsidiary and DraftKings Inc. have settled a suit that accused the sports betting company of using athletes' images without permission to promote its gambling platform, according to a Pennsylvania federal judge's order dismissing the case.
-
April 07, 2026
Fed. Circ. Backs PTAB Decision On Intuit Patent Challenge
The Federal Circuit on Tuesday backed a decision by the Patent Trial and Appeal Board that software company Intuit had not shown that any of the patent claims it challenged in a patent that covers synchronized internet browsing were invalid.
-
April 07, 2026
Dow Jones Wins Order For More Months Of Perplexity AI Logs
A Manhattan federal judge has ordered Perplexity AI to turn over seven additional months of internal user‑activity logs in a copyright lawsuit brought by Dow Jones and other publishers, rejecting Perplexity's argument that producing the data would be unduly burdensome.
-
April 07, 2026
Wildfire App Wants Competitor's Launch Blocked In TM Case
A company that operates a phone application that gives out information about wildfires has asked a California federal judge to block the launch of a competing wildfire app made by public safety software company Intterra.
-
April 07, 2026
Boehringer Wants Generic For Blockbuster Jardiance Blocked
Boehringer Ingelheim has hit an Arizona business with a patent lawsuit in Delaware federal court seeking to stop it from moving forward with a generic version of its diabetes drug Jardiance.
-
April 07, 2026
Pregnant DLA Piper Atty Recounts Firing: 'This Feels Wrong'
A former associate who claims DLA Piper unlawfully fired her after she announced she was pregnant told a Manhattan federal jury Tuesday that she got positive feedback as she worked with large corporate clients and was "shocked" when she was terminated.
-
April 06, 2026
Vape Seller To Stop Selling Alleged Fake Urine Brand Knockoff
An Alabama smoke shop has agreed to no longer sell alleged knockoffs of Quick Fix, a brand of synthetic urine, according to a joint filing made by the retailer and the brand's maker, which filed suit claiming the counterfeits were hurting its business.
-
April 06, 2026
Morgan Lewis Beats DQ Bid In Meta Smart Glasses IP Suit
Morgan Lewis & Bockius LLP can remain Oakley Inc.'s counsel in Solos Technology Ltd.'s lawsuit accusing the eyewear brand and Meta Platforms of infringing smart eyewear patents, a Massachusetts federal judge ruled Monday, saying the firm's 2019 representation of a corporation Solos spun out from didn't warrant its disqualification.
-
April 06, 2026
ITC Keeps Stiiizy Vape Import Ban In Place Pending Appeal
The U.S. International Trade Commission won't pause the import and sales bans imposed on cannabis vape company Stiiizy while the company pursues an appeal of the agency's patent infringement ruling in its dispute with rival Pax Labs.
-
April 06, 2026
Bausch, MSN Laboratories Settle Patent Battle Over IBS Drug
Bausch Health and MSN Laboratories have ended their New Jersey patent fight over the irritable bowel medication Trulance after reaching a confidential settlement, filing a stipulation of dismissal that lets MSN keep its patent challenge and lifts the 30‑month stay blocking FDA approval of its proposed generic drug.
-
April 06, 2026
Full Fed. Circ. Urged To Course Correct On Design Patent Test
The full Federal Circuit needs to return design patent infringement to a similarities-focused test, rather than one looking at differences between designs, massage device-maker Range of Motion Products LLC said in a bid to revive its suit against Armaid Co.
-
April 06, 2026
Judge Slashes Damages For Natera In Invitae Patent Case
A Delaware federal judge knocked nearly $10 million off a $19.35 million damages award for Natera Inc. on Monday, but added supplemental damages and interest to a patent infringement verdict against Invitae Corp. related to cancer testing technology.
-
April 06, 2026
Highland Mint Settles In Barry Sanders Photo IP Suit
A sports memorabilia company has reached a settlement with a professional photographer in a copyright infringement suit over a statue of former Detroit Lions running back Barry Sanders, the parties told a New York federal court, asking to be excused from a settlement conference scheduled for Tuesday.
-
April 06, 2026
Settlement In Sight For Amway, Supplement Co. In TM Dispute
A trademark dispute over gut health products between a supplement-maker and multi-level marketing giant Amway Corp. may be headed for settlement, according to a motion from Begin Health Inc. asking a North Carolina federal court to delay a coming hearing.
-
April 06, 2026
Udio Urges Illinois Court To Ax AI Music Copyright Suit
Artificial intelligence music platform Udio has asked a Chicago federal judge to dismiss a proposed class action from a group of songwriters who accuse it of copyright infringement, arguing that simply operating a website that is accessible nationally does not give the Illinois court authority to hear claims over how Udio's technology was developed.
Expert Analysis
-
Opinion
Fed. Circ. Must Bury Design Patent Doctrinal Zombies
After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.
-
Why La. Ruling May Open NIL Deals For Int'l Student-Athletes
A Louisiana federal court's decision to deny a motion to dismiss in Poa v. Jaddou, a case over whether international student-athletes may engage in name, image and likeness deals, signals that courts are willing to challenge rigid interpretations of immigration law in light of modern collegiate athletics, say attorneys at Shook Hardy.
-
Weighing Confusion Claims In Shoes-NFL Steakhouse TM Suit
A recent New York federal infringement complaint by 1587 Sneakers against Patrick Mahomes and Travis Kelce's Kansas City steakhouse 1587 Prime confronts the thorny question of how much operating in different industries should factor into likelihood-of-confusion analysis and why consumer perception can matter most in trademark fights, says Nate Garhart at Spencer West.
-
Unique Issues Facing Brand-Compounder Patent Litigation
Recent litigation and potential enforcement action against Hims & Hers Health raise questions about how compounders and branded pharmaceuticals companies would be positioned in patent litigation as compared to generics companies, which would require strategies different from those that would be used in traditional Hatch-Waxman Act litigation, say attorneys at Morgan Lewis.
-
Series
Volunteering With Scouts Makes Me A Better Lawyer
Serving as an assistant scoutmaster for my son’s troop reaffirmed several skills and principles crucial to lawyering — from the importance of disconnecting to the value of morality, says Michael Warren at McManis Faulkner.
-
AI Communications May Be Discoverable In Patent Litigation
A New York federal court's recent determination that a defendant's correspondence with an artificial intelligence tool was not protected by attorney-client privilege may have significant ramifications for patent matters, highlighting the risk of AI use in patent prosecution and litigation tasks, say attorneys at Seed IP.
-
Series
Law School's Missed Lessons: In Court, It's About Storytelling
Law school provides doctrine, cases and hypotheticals, but when lawyers step into the courtroom, they must learn the importance of clarity, credibility, memorability and preparation — in other words, how to tell simple, effective stories, say Nicholas Steverson and Danielle Trujillo at Wheeler Trigg, and Lisa DeCaro at Courtroom Performance.
-
High Court's 'Skinny Label' Case May Tackle Wider Questions
The U.S. Supreme Court's upcoming decision in Hikma v. Amarin will have important ramifications for broader debates over what defines a generic version of a drug, and the pending case is already altering patent practice, say attorneys at Taft.
-
Aligning Microsoft Tools With NYC Bar AI Recording Guidance
The New York City Bar Association’s recently issued formal opinion, providing ethical guidance on artificial intelligence-assisted recording, transcription and summarization, raises immediate questions about data governance and e-discovery for companies that use Microsoft 365 and Copilot, say Staci Kaliner, Martin Tully and John Collins at Redgrave.
-
FDA's Biosimilarity Guidance Holds Uncertain Implications
The U.S. Food and Drug Administration's new draft guidance aimed at simplifying the biosimilarity demonstration process may not be enough to overcome the barriers that have historically constrained biosimilar competition, and could affect biosimilar access in unexpected ways, say analysts at Analysis Group.
-
5 Different AI Systems Raise Distinct Privilege Issues
A New York federal court’s recent U.S. v. Heppner decision, holding that a defendant’s use of Claude was not privileged, only addressed one narrow artificial intelligence system, but lawyers must recognize that the spectrum of AI tools raises different confidentiality and privilege questions, says Heidi Nadel at HP.
-
Making Effective Use Of DOD's 'Patent Holiday' Program
The U.S. Department of Defense's new defense patent holiday program, designed to let companies experiment with otherwise latent technology without paying typical up-front fees, can help contractors enter new technical domains and markets, but requires careful attention to export controls and patent infringement risks, say attorneys at Sterne Kessler.
-
Labubu Shows Value Of Patents When Viral Brands Plateau
The rapid ascent of Labubu dolls demonstrated how character-driven products can scale globally without relying heavily on U.S. patents, but risk profiles change as growth stabilizes, and copyright and trade dress protections may not provide enough protection in the long term, says Tina Dorr at Barnes & Thornburg.
-
Opinion
AI-Assisted Arbitration Needs Safeguards To Ensure Fairness
As tribunals and arbitral institutions increasingly use artificial intelligence tools in their decision-making processes, clear disclosure standards and procedural safeguards are necessary to ensure that efficiency gains do not erode the fairness principles on which arbitration depends, says Alexander Lima at Wesco International.
-
What Recent Dataset Suits Signal For AI Training Litigation
Plaintiffs are moving away from abstract debates about artificial intelligence at large and toward dataset provenance, and three filings illustrate how provenance is pled using public dataset documentation, archives and discovery‑ready allegations about copying, retention and downstream handling, says Yulia Leshchenko at Name & Fame.